Who
Alan W. Dunton
Director
Company insider
Files Form 4 as: Director, Palatin Technologies; Director, CorMedix; Director, Oragenics; Director, Gyre Therapeutics; Director, Epicept; Director, MediciNova; Chief Exec Officer & President, Panacos Pharmaceuticals; Director, Adams Respiratory Therapeutics.
In numbers
- Trades disclosed
- 205
- Buys
- 19
- Sells
- 25
- Bought
- $4.2M
- Sold
- $1.2M
- Companies
- 8
- Companies where not an officer
- 7
- First trade
- 11 May 2006
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code Z | —2,200 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code Z | —2,200 at $0.00 | filing |
| 26 Jan 2026filed 27 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code A | —30,453 at $0.00 | filing |
| 26 Jan 2026filed 27 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code A | —30,453 at $0.00 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code M | $81K20,000 at $4.03 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Sold | $260K20,000 at $13.00 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CRMD CorMedixoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CRMD CorMedixoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code M | $81K20,000 at $4.03 | filing |
| 30 Dec 2025filed 2 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Sold | $260K20,000 at $13.00 | filing |
| 11 Dec 2025filed 15 Dec 2025 | OGEN Oragenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,200 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,200 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code A | —1,000 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code A | —1,000 at $0.00 | filing |
| 12 Sep 2025filed 16 Sep 2025 | CRMD CorMedixoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 12 Sep 2025filed 16 Sep 2025 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code M | $36K10,000 at $3.55 | filing |
| 12 Sep 2025filed 16 Sep 2025 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Sold | $131K10,000 at $13.13 | filing |
| 13 Jun 2025filed 17 Jun 2025 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code P | —363,636 at $0.00 | filing |
| 13 Jun 2025filed 17 Jun 2025 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Bought | $4.0M200 at $20,000.00 | filing |
News
Head-To-Head Survey: Inhibikase Therapeutics (NASDAQ:IKT) versus CorMedix (NASDAQ:CRMD)CRMD · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Alan W. Dunton; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.
Sectors
Related people
Nobody else traded the same names lately.